I don't understand the point of Novartis duplicating the Phase 3 trial after the current one is finished - I'm obviously missing something
I don't understand the point of Novartis duplicating the Phase 3...
-
- There are more pages in this discussion • 2,625 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.3¢ |
Change
-0.003(0.27%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $381.2K | 414.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 349 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 39051 | 20 |
View Market Depth
| Last trade - 10.47am 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |